We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$484M
AUM Growth
+$36.9M
Cap. Flow
+$6.09M
Cap. Flow %
1.26%
Top 10 Hldgs %
26.56%
Holding
273
New
13
Increased
78
Reduced
63
Closed
4

Top Buys

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$973K
2
WY icon
Weyerhaeuser
WY
+$638K
3
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$453K
4
AIG icon
American International
AIG
+$430K
5
VNO icon
Vornado Realty Trust
VNO
+$423K

Top Sells

Rank Stock Value
1
NWSA
NEWS CORPORATION CL-A
NWSA
+$326K
2
SRPT icon
Sarepta Therapeutics
SRPT
+$272K
3
CP icon
Canadian Pacific Kansas City
CP
+$231K
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$224K
5
AMGN icon
Amgen
AMGN
+$169K

Sector Composition

Rank Sector Weight
1 Healthcare 22.9%
2 Industrials 12.46%
3 Consumer Staples 12.36%
4 Energy 9.49%
5 Technology 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIG icon
101
American International
AIG
$41.8B
$1M 0.21%
20,590
+9,050
+78% +$430K
MTW icon
102
Manitowoc
MTW
$497M
$997K 0.21%
56,302
– –
SWK icon
103
Stanley Black & Decker
SWK
$14.9B
$990K 0.2%
10,931
– –
LUMN icon
104
Lumen
LUMN
$6.76B
$982K 0.2%
31,279
-4,395
-12% -$150K
PX
105
DELISTED
Praxair Inc
PX
$976K 0.2%
8,122
– –
GS.PRC icon
106
Goldman Sachs Group Inc Series C Preferred Stock
GS.PRC
$152M
$967K 0.2%
47,650
-500
-1% -$11.1K
VO icon
107
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$961K 0.2%
37,500
+5,700
+18% +$143K
MAR icon
108
Marriott International
MAR
$99B
$956K 0.2%
22,721
– –
BP icon
109
BP
BP
$114B
$939K 0.19%
27,303
+3,637
+15% +$125K
GEN icon
110
Gen Digital
GEN
$16.3B
$930K 0.19%
37,575
– –
VB icon
111
Vanguard Morningstar Small-Cap ETF
VB
$79.6B
$929K 0.19%
9,070
+750
+9% +$74.8K
NSC icon
112
Norfolk Southern
NSC
$75B
$920K 0.19%
11,895
– –
K
113
DELISTED
Kellanova
K
$915K 0.19%
16,587
– –
ABT icon
114
Abbott
ABT
$183B
$913K 0.19%
27,514
+1
+0% +$35
VNQI icon
115
Vanguard Global ex-US Real Estate ETF
VNQI
$3.56B
$885K 0.18%
15,600
– –
BML.PRL
116
Bank of America Depository Shares Series 5
BML.PRL
$308M
$874K 0.18%
42,900
+500
+1% +$10.8K
IFGL icon
117
iShares International Developed Real Estate ETF
IFGL
$84M
$870K 0.18%
25,940
– –
MJN
118
DELISTED
Mead Johnson Nutrition Company
MJN
$870K 0.18%
11,716
– –
VZ icon
119
Verizon
VZ
$193B
$869K 0.18%
18,614
+3,901
+27% +$190K
GSK icon
120
GSK
GSK
$104B
$863K 0.18%
13,758
-800
-5% -$51.5K
TM icon
121
Toyota
TM
$227B
$855K 0.18%
6,675
– –
GMF icon
122
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$421M
$849K 0.18%
11,300
+2,210
+24% +$163K
VBK icon
123
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.2B
$843K 0.17%
7,366
-100
-1% -$11K
TWX
124
DELISTED
Time Warner Inc
TWX
$834K 0.17%
13,211
-1,043
-7% -$62.4K
MA icon
125
Mastercard
MA
$510B
$807K 0.17%
12,000
– –
3 4
5
6 7

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Gerald L. Ray & Associates held 273 positions worth $484M, up 8.3% from $447M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Gerald L. Ray & Associates's Q3 2013 filing shows 13 new, 78 increased, 63 reduced and 4 closed positions. Its largest new stake was Acadia Pharmaceuticals: 46,550 shares worth $1.28M. The largest sale was NEWS CORPORATION CL-A, an estimated $326K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q3 2013 buy was Acadia Pharmaceuticals: 46,550 shares worth $1.28M.
  • Gerald L. Ray & Associates added most to American International in Q3 2013, an estimated $430K increase.
  • Gerald L. Ray & Associates's biggest Q3 2013 reduction was Regeneron Pharmaceuticals, cutting an estimated $224K.
  • Gerald L. Ray & Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $326K.
  • Gerald L. Ray & Associates's ten largest holdings make up 27% of its $484M portfolio in Q3 2013.
  • Gerald L. Ray & Associates opened 13 new positions and closed 4 in Q3 2013.
  • Gerald L. Ray & Associates's portfolio value rose 8.3% quarter-over-quarter to $484M.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2013, filed 5 Nov 2013.